Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation (Q36307015)

13 August 2017

1 reference

4 August 2022

1 reference

Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation (English)

1 reference

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

13 August 2017

cerebrovascular disease

1 reference

13 December 2019

1 reference

27 September 2019

1 reference

28 September 2019

Tocilizumab

1 reference

PubMed ID

28289923

Aicardi-Goutieres syndrome

object has role

subject heading

object named as

Aicardi-Goutières syndrome

1 reference

Moyomoya

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Heng Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

13 March 2017

1 reference

13 August 2017

1 June 2017

9 references

22 March 2019

25 April 2019

17 June 2019

27 September 2019

28 September 2019

27 November 2019

13 December 2019

25 May 2022

4 August 2022

Clinical Rheumatology

10 references

22 March 2019

25 April 2019

17 June 2019

27 September 2019

28 September 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

25 May 2022

4 August 2022

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1445-1451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

1 June 2020

copyright license

9 references

22 March 2019

25 April 2019

17 June 2019

27 September 2019

28 September 2019

27 November 2019

13 December 2019

25 May 2022

on focus list of Wikimedia project

4 August 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Biotherapies in large vessel vasculitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Biologics in vasculitides: Where do we stand, where do we go from now?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Management of Takayasu arteritis: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

New treatment strategies in large-vessel vasculitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Chilblain lupus induced by TNF-α antagonists: a case report and literature review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Biologic treatment of large-vessel vasculitides.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Trex1 prevents cell-intrinsic initiation of autoimmunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

SAM domains: uniform structure, diversity of function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

The HD domain defines a new superfamily of metal-dependent phosphohydrolases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Schönlein Purpura

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5486483

Familial Aicardi-Goutières syndrome due toSAMHD1mutations is associated with chronic arthropathy and contractures

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-017-3600-2

Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-017-3600-2

Successful treatment of lupus pernio with adalimumab

21 January 2018

1 reference

12 December 2020

Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica

1 reference

12 December 2020

Tocilizumab, an effective treatment for relapsing giant cell arteritis

1 reference

12 December 2020

[Biomarkers associated with unresponsiveness to IVIG in children with Kawasaki disease]

1 reference

12 December 2020

Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura

1 reference

12 December 2020

Tocilizumab treatment for neuro-Behcet's disease, the first report

1 reference

12 December 2020

MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu's arteritis

1 reference

12 December 2020

Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series

1 reference

12 December 2020

Tocilizumab: a novel therapy for patients with large-vessel vasculitis

1 reference

12 December 2020

Production of interleukin 6 by granulomas of giant cell arteritis

1 reference

12 December 2020

10.1007/S10067-017-3600-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28289923%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference